Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-002277
Filing Date
2017-02-13
Accepted
2017-02-13 17:16:33
Documents
1
Period of Report
2017-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3983
  Complete submission text file 0001179110-17-002277.txt   5456
Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Quirk Gerald E (Reporting) CIK: 0001479603 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37813 | Film No.: 17600676

Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations